{"lastClose": 4.699999809265137, "len": 975, "date": "2023-02-15", "alpha_1": -0.7564350147685431, "beta_1": 0.9145103376848975, "drawup_1": 0.7155424508464454, "natr_1": 18.46781934107054, "sup_1": -1.036170162830089, "res_1": 0.7361702845757511, "bullPattern_1": ["HIKKAKE"], "bearPattern_1": ["CLOSINGMARUBOZU", "LONGLINE"], "rsi_1": 45.60439308517976, "adx_1": 43.541051813238674, "drawdown_1": -0.8070175398354672, "stratHoldSharpe_1": -0.6452371225585534, "stratHoldAlpha_1": 250.46282128461323, "stratHoldDrawdown_1": -0.7320746044653348, "alpha_3mo": -0.22915515689640875, "beta_3mo": 1.5605389261065672, "drawup_3mo": 0.20805376931257258, "natr_3mo": 18.46781934107054, "sup_3mo": -0.11219853660361115, "res_3mo": 0.013049680820073496, "bullPattern_3mo": [], "bearPattern_3mo": ["BELTHOLD", "CLOSINGMARUBOZU", "LONGLINE", "MARUBOZU"], "rsi_3mo": 34.21051558364435, "adx_3mo": 26.436831710985597, "drawdown_3mo": -0.20178573815798317, "stratHoldSharpe_3mo": -0.8949855006667745, "stratHoldAlpha_3mo": 250.54392161064123, "stratHoldDrawdown_3mo": -0.18199715788665627, "Sector": "Health Care", "IPO Year": 2019.0, "Industry": "Biotechnology: Biological Products (No Diagnostic Substances)", "Market Cap": 384112731, "Name": "NGM Biopharmaceuticals Inc.", "Country": "United States", "alpha%_1": 0.015408049330917717, "beta%_1": 0.4433058397177934, "drawup%_1": 0.6687914569766436, "natr%_1": 0.9999999999415629, "drawdown%_1": 0.016767391713488056, "stratHoldSharpe%_1": 0.13516983388325382, "stratHoldAlpha%_1": 0.011289605444815994, "stratHoldDrawdown%_1": 0.017693085365942097, "alpha%_3mo": 0.19341184118868904, "beta%_3mo": 0.8578540484526873, "drawup%_3mo": 0.39433270103223406, "natr%_3mo": 0.9999999998689356, "drawdown%_3mo": 0.23392143666504356, "stratHoldSharpe%_3mo": 0.10048572460805205, "stratHoldAlpha%_3mo": 0.07296814537684831, "stratHoldDrawdown%_3mo": 0.23615737200235354}